{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:36:11Z","timestamp":1793799371208,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016168","name":"Ludwig Boltzmann Gesellschaft","doi-asserted-by":"publisher","award":["LBG_KFG_22_32"],"award-info":[{"award-number":["LBG_KFG_22_32"]}],"id":[{"id":"10.13039\/501100016168","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cgh.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:57:56Z","timestamp":1781711876000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stage-Specific Drivers of Clinical Progression in Advanced Chronic Liver Disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8181-9146","authenticated-orcid":false,"given":"Benedikt","family":"Simbrunner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bofill Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Laurin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Balcar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Jachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt Silvester","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Th\u00f6ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sebesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Dominik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Friedrich","family":"St\u00e4ttermayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-0017","authenticated-orcid":false,"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.06.011_bib1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2026.06.011_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00508-023-02229-w","article-title":"Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)","volume":"135","author":"Mandorfer","year":"2023","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.cgh.2026.06.011_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/HEP.0000000000000652","article-title":"Further decompensation in cirrhosis: results of a large multicenter cohort study supporting Baveno VII statements","volume":"79","author":"D'Amico","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.06.011_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.06.011_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/hep.32220","article-title":"Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies","volume":"75","author":"K\u00f6nigshofer","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.cgh.2026.06.011_bib10","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cld.2021.01.003","article-title":"Prevention of first decompensation in advanced chronic liver disease","volume":"25","author":"Mandorfer","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2026.06.011_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL Clinical Practice Guidelines on acute-on-chronic liver failure","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib13","article-title":"Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis","volume":"5","author":"Simbrunner","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2026.06.011_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.cgh.2026.06.011_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis","volume":"68","author":"Turco","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2023-329923","article-title":"Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis","volume":"73","author":"Juanola","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.06.011_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s12072-021-10203-9","article-title":"The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes","volume":"15","author":"Hartl","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2026.06.011_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s12072-020-10112-3","article-title":"Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis","volume":"14","author":"Simbrunner","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2026.06.011_bib21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/liv.14498","article-title":"Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease","volume":"40","author":"Simbrunner","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.06.011_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cgh.2021.07.012","article-title":"Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death","volume":"20","author":"Jachs","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib23","doi-asserted-by":"crossref","DOI":"10.3791\/58819","article-title":"Measurement of the hepatic venous pressure gradient and transjugular liver biopsy","author":"Reiberger","year":"2020","journal-title":"J Vis Exp"},{"key":"10.1016\/j.cgh.2026.06.011_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/hep.31070","article-title":"Ordinal outcomes are superior to binary outcomes for designing and evaluating clinical trials in compensated cirrhosis","volume":"72","author":"D'Amico","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.30314","article-title":"Prioritization of therapeutic targets and trial design in cirrhotic portal hypertension","volume":"69","author":"Abraldes","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhep.2024.12.017","article-title":"Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis","volume":"83","author":"Fortea","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib29","article-title":"Where does TIPS fit in the management of patients with cirrhosis?","volume":"2","author":"Garc\u00eda-Pag\u00e1n","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2026.06.011_bib30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib31","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2026.06.011_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12703\/r\/10-48","article-title":"Recent advances in the understanding and management of hepatorenal syndrome","volume":"10","author":"Simbrunner","year":"2021","journal-title":"Fac Rev"},{"key":"10.1016\/j.cgh.2026.06.011_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Th\u00e9venot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib34","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib35","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.06.011_bib36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.06.011_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jama.2024.27441","article-title":"Simvastatin and rifaximin in decompensated cirrhosis: a randomized clinical trial","volume":"333","author":"Pose","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2026.06.011_bib38","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","author":"Abraldes","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.06.011_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.30885","article-title":"Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy","volume":"71","author":"Mandorfer","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.06.011_bib40","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/liv.15676","article-title":"Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis","volume":"43","author":"Hofer","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.06.011_bib41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/apt.17908","article-title":"Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis","volume":"59","author":"Hofer","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.06.011_bib42","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/liv.15365","article-title":"Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease","volume":"42","author":"Simbrunner","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.06.011_bib43","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/apt.70407","article-title":"Biomarkers of extracellular matrix remodelling are linked to severity and outcome of advanced chronic liver disease","volume":"63","author":"Simbrunner","year":"2026","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.06.011_bib44","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/apt.17945","article-title":"Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease","volume":"59","author":"Dominik","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.06.011_bib45","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.14522","article-title":"Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity","volume":"47","author":"Mandorfer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.06.011_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.718783","article-title":"Bile acids, liver cirrhosis, and extrahepatic vascular dysfunction","volume":"12","author":"Sauerbruch","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.cgh.2026.06.011_bib48","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.06.011_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.06.011_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jhep.2022.09.005","article-title":"Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis","volume":"78","author":"Zanetto","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib51","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/gutjnl-2023-330584","article-title":"Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers","volume":"73","author":"Trebicka","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.06.011_bib52","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.06.011_bib53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.2009.203166","article-title":"Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease","volume":"59","author":"Parkes","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.06.011_bib54","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"La Mura","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.06.011_bib55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/liv.13201","article-title":"Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis","volume":"37","author":"Horvatits","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.06.011_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2024.05.033","article-title":"Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD","volume":"81","author":"Paternostro","year":"2024","journal-title":"J Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526004453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526004453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:56:52Z","timestamp":1786049812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526004453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S1542356526004453"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.06.011","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stage-Specific Drivers of Clinical Progression in Advanced Chronic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}